Fluicell AB (publ) operates as a life science company, provides platforms and research solutions for bioprinting and single-cell biology. The company offers BIOPEN, a microfluidic platform for high-precision single-cell solution delivery that enables to control the cell microenvironment without moving or disturbing the cells; Biozone 6 that generate dose-response curves or study the effects of multiple drug compounds; and Dynaflow Resolve system, an ion channel screening platform, which allows to record various ion channel current in patch-clamp recording configuration. It also provides Biopixlar, a 3D single-cell bioprinting platform that enables high cell viability and cell-to-cell communication; and Biopixlar AER, an easy-to-use 3D bioprinting platform that fits into your fume hood or biosafety cabinet. The company also offers accessory and consumable products for bioprinting and single-cell biology. The company was incorporated in 2012 and is based in Mölndal, Sweden.
तुलना करने के लिए मीट्रिक्स | FLUIC | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधFLUICपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | −1.4x | −6.9x | −0.6x | |
PEG अनुपात | 0.00 | −0.09 | 0.00 | |
क़ीमत/बुक | 1.3x | 1.8x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 1.1x | 4.0x | 3.4x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 0.0% | 39.6% | |
उचित मूल्य अपसाइड | अनलॉक करें | −9.0% | 5.2% | अनलॉक करें |